Cargando…
Designing a VAR2CSA-based vaccine to prevent placental malaria()
Placental malaria (PM) due to Plasmodium falciparum is a major cause of maternal, fetal and infant mortality, but the mechanisms of pathogenesis and protective immunity are relatively well-understood for this condition, providing a path for vaccine development. P. falciparum parasites bind to chondr...
Autores principales: | Fried, Michal, Duffy, Patrick E. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5077158/ https://www.ncbi.nlm.nih.gov/pubmed/26469717 http://dx.doi.org/10.1016/j.vaccine.2015.10.011 |
Ejemplares similares
-
Placental malaria vaccine candidate antigen VAR2CSA displays atypical domain architecture in some Plasmodium falciparum strains
por: Doritchamou, Justin Y. A., et al.
Publicado: (2019) -
Structural basis for placental malaria mediated by Plasmodium falciparum VAR2CSA
por: Ma, Rui, et al.
Publicado: (2021) -
A conformational epitope in placental malaria vaccine antigen VAR2CSA: What does it teach us?
por: Doritchamou, Justin Y. A., et al.
Publicado: (2023) -
A single full-length VAR2CSA ectodomain variant purifies broadly neutralizing antibodies against placental malaria isolates
por: Doritchamou, Justin YA, et al.
Publicado: (2022) -
Allelic variants of full-length VAR2CSA, the placental malaria vaccine candidate, differ in antigenicity and receptor binding affinity
por: Renn, Jonathan P., et al.
Publicado: (2021)